Citi Maintains Cardinal Health(CAH.US) With Hold Rating, Raises Target Price to $140
Citigroup Adjusts Price Target on Cardinal Health to $140 From $130, Maintains Neutral Rating
Cardinal Health (CAH) Receives a Hold From Citi
Morgan Stanley Maintains Cardinal Health(CAH.US) With Buy Rating, Maintains Target Price $142
BofA Securities Maintains Cardinal Health(CAH.US) With Buy Rating
Cardinal Health Is Maintained at Buy by B of A Securities
Cardinal Health Analyst Ratings
Leerink Partners Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $161
Mizuho Securities Maintains Cardinal Health(CAH.US) With Buy Rating, Raises Target Price to $150
Cardinal Health Analyst Ratings
Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $150
Baird Maintains Cardinal Health(CAH.US) With Buy Rating, Cuts Target Price to $153
Baird Adjusts Cardinal Health Price Target to $153 From $154, Maintains Outperform Rating
Jefferies Upgrades Cardinal Health(CAH.US) to Buy Rating, Raises Target Price to $150
Cardinal Health's Growth Potential Under New Management: Buy Rating Backed by Strong Earnings and Strategic Acquisitions
Cardinal Health Upgraded to Buy From Hold at Jefferies
Cardinal Health Is Maintained at Neutral by JP Morgan
Cardinal Health Price Target Raised to $136.00/Share From $135.00 by Wells Fargo
Cardinal Health Analyst Ratings
Argus Research Initiates Cardinal Health(CAH.US) With Buy Rating, Announces Target Price $148